Clinical trial · Interventional
Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study
NCT01685346CI-TRIAL-00018512terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Research Cancelled
Summary
Brief summary (as posted)
This is a pilot study to test the hypothesis that biofeedback-mediated stress management (BFSM) training can be used to reduce distress and enhance quality of life in patients with non-small cell lung cancer (NSCLC). Most patients with advanced NSCLC have significant physical symptoms, but even those who do not have physical symptoms have high levels of anxiety and depression.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced (Stage IV) Non-small Cell Lung Cancer (NSCLC) | Lung Non-Small Cell Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biofeedback-mediated stress management (BFSM) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Biofeedback
- description
- biofeedback-mediated stress management (BFSM)
- interventionNames
- Behavioral: biofeedback-mediated stress management (BFSM)
Primary outcomes (1)
- measure
- Number of patients that are able to return for eight visits of BFSM
- timeFrame
- 16 weeks
- description
- Keep track of how many visits the patients attend, how many they cancel, and what other difficulties are encounter in getting them to return for eight visits.
Secondary outcomes (10)
- measure
- Number of patients able to complete the Quality of Life (QOL) questionnaires
- timeFrame
- 16 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a new diagnosis of advanced (stage IV) non-small cell lung cancer (NSCLC) * ECOG performance status 0-1. * Plan to receive care at the Taussig Cancer Center. Exclusion Criteria: * Non-local patients, who will not have the ability to return for 8 study visits. * Patients who are unable to speak and understand English readily, * Patients with significant cognitive impairment.
References
Publications (0)
Data not yet available
No reference posted for this study.